Detalhe da pesquisa
1.
Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
J Vasc Interv Radiol
; 34(9): 1547-1555, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210030
2.
Metagenomics and chemotherapy-induced nausea: A roadmap for future research.
Cancer
; 128(3): 461-470, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643945
3.
Immunotherapy in Biliary Tract Cancers: Where Are We?
Curr Oncol Rep
; 24(12): 1821-1828, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192517
4.
Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers.
Cancer
; 127(8): 1293-1300, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33289918
5.
A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer.
Br J Cancer
; 124(11): 1803-1808, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828254
6.
The Application of Circulating Tumor DNA in the Screening, Surveillance, and Treatment Monitoring of Colorectal Cancer.
Ann Surg Oncol
; 28(3): 1845-1858, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776184
7.
Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy.
Rep Pract Oncol Radiother
; 26(1): 29-34, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33948299
8.
A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer.
Cancer
; 126(15): 3464-3470, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32453456
9.
Partial Splenic Artery Embolization in 35 Cancer Patients: Results of a Single Institution Retrospective Study.
J Vasc Interv Radiol
; 31(4): 584-591, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471193
10.
Modeling precision genomic-based radiation dose response in rectal cancer.
Future Oncol
; 16(30): 2411-2420, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32686956
11.
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
Cancer
; 124(15): 3118-3126, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29905927
12.
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
J Vasc Interv Radiol
; 29(8): 1101-1108, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042074
13.
EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience.
Oncology
; 92(4): 190-196, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152526
14.
Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.
Cancer
; 122(18): 2828-35, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27244218
15.
Clinicopathologic and survival analysis of resected ampullary adenocarcinoma.
J Surg Oncol
; 114(2): 170-5, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158031
16.
ASO Author Reflections: Clinical Utility of Circulating Tumor DNA Analysis in Colorectal Cancer: Current Status.
Ann Surg Oncol
; 27(Suppl 3): 890, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32812106
17.
Progress in the treatment of anal cancer: an overview of the latest investigational drugs.
Expert Opin Investig Drugs
; 33(2): 145-157, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38275174
18.
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report.
J Gastrointest Oncol
; 15(1): 485-490, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482231
19.
Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab in Mismatch Repair-Proficient Advanced Refractory Colorectal Cancer.
Cancers (Basel)
; 16(3)2024 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339307
20.
Tumor Response-speed Heterogeneity as a Novel Prognostic Factor in Patients With Metastatic Colorectal Cancer.
Am J Clin Oncol
; 46(2): 50-57, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36606664